Physician Clinical Practice Tools to Navigate COVID-19 Therapies.

Updated on: February 28, 2022

The Health Care Provider Information on sotrovimab (Xevudy) and nirmatrelvir/ritonavir (Paxlovid) was updated to remove the recommendation to wait 90 days following treatment with monoclonal antibodies before vaccination.

CDC

otrovimab (Xevudy) and nirmatrelvir/ritonavir (Paxlovid)

Information is considered to be true and correct at the date of publication, changes in circumstances after the time of publication may impact on the accuracy of the information.